Belém Sampaio-Marques graduated in Biology from the University of the Azores in 2003 and obtained a PhD in Health Sciences from the University of Minho in 2012. Between 2013 and 2019, she developed postdoctoral studies on the study and elucidation of mechanisms related to aging and age-related diseases, using the yeast Saccharomyces cerevisiae as a model for neurodegenerative disease, namely Parkinson’s disease. Since 2019, she has been working as a Junior Researcher at the ICVS and also serves as an Assistant Professor at the School of Medicine, University of Minho. Her research focuses on elucidating the molecular mechanisms and cellular processes of aging and age-related diseases. As of June 2023, she has shifted her research focus towards developing models to study Parkinson’s disease and exploring the role of the secretome of mesenchymal stem cells (MSCs) in neuroprotection and repair. Her track record is currently reflected in forty-eight publications in international peer-reviewed journals (>2200 citations and h-index=20) and two book chapters. She has supervised one PhD and five MSc students. She has served as an ad hoc reviewer for more than 20 journals and some funding agencies.
Belém Sampaio-Marques graduated in Biology from the University of the Azores in 2003 and obtained a PhD in Health Sciences from the University of Minho in 2012. Between 2013 and 2019, she developed postdoctoral studies on the study and elucidation of mechanisms related to aging and age-related diseases, using the yeast Saccharomyces cerevisiae as a model for neurodegenerative disease, namely Parkinson’s disease. Since 2019, she has been working as a Junior Researcher at the ICVS and also serves as an Assistant Professor at the School of Medicine, University of Minho. Her research focuses on elucidating the molecular mechanisms and cellular processes of aging and age-related diseases. As of June 2023, she has shifted her research focus towards developing models to study Parkinson’s disease and exploring the role of the secretome of mesenchymal stem cells (MSCs) in neuroprotection and repair. Her track record is currently reflected in forty-eight publications in international peer-reviewed journals (>2200 citations and h-index=20) and two book chapters. She has supervised one PhD and five MSc students. She has served as an ad hoc reviewer for more than 20 journals and some funding agencies.